Equity Overview
Price & Market Data
Price: $24.13
Daily Change: -$12.57 / 52.09%
Range: $22.22 - $36.30
Market Cap: $17,309,661,184
Volume: 24,670,404
Performance Metrics
1 Week: -4.65%
1 Month: 17.97%
3 Months: -1.24%
6 Months: 13.96%
1 Year: 529.1%
YTD: 31.49%
Company Details
Employees: 159
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.